A comprehensive prognostic and immunological analysis of telomere-related lncRNAs in kidney renal clear cell carcinoma
Figure 3.Prognosis value of the TRLs prognostic signature in the training; testing; and entire cohorts; respectively. (A–C) The distributions of risk scores. (D–F) The survival time and survival status. (G–I) Heatmaps of 9 TRLs expression.